Institutional Investors

The income-producing real estate company G City has removed the approval of a special compensation package for incoming CEO Keren Khalifa from its shareholders' meeting agenda following opposition from institutional investors. Market sources previously cited this move as a factor in the collapse of the deal to sell G City to Tzahi Abu.

In recent months, Israeli investment houses have begun actively acquiring hedge funds. Experts are debating whether this is a strategic business expansion or an overpayment for assets with questionable future returns.

Amit Gal, head of the Capital Market Authority, has questioned the involvement of the Meitav investment house in the company Orion. This move has sparked a debate over the limits of institutional activism and the balance between protecting savers and market structure.

The Capital Markets Authority is demanding data from institutional bodies regarding their votes at public company meetings over the last 3 years. This involves hundreds of votes per body, and the institutions have turned to their voting advisory body on compensation issues to help them meet the Authority's deadline.

The Capital Market Authority is intervening for the first time to limit institutional involvement in public company management. The regulator is demanding clarifications from the Mor investment house regarding its actions in Orion.

For the second time in a year, institutional investors have rejected Elco Medical's proposal to outsource US software distribution to the daughter of controlling shareholder Moshe Ben-Shaul.